A significant (p < 0.05) increase in the NF-κB level and a sustainable (p < 0.05) decrease in the IL-10 level were observed in the liver of NAFLD rats with respect to the control group, indicative of hepatic inflammation. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.